Insulet (NASDAQ:PODD – Get Rating) had its price target reduced by equities researchers at Wells Fargo & Company from $357.00 to $345.00 in a report released on Friday, The Fly reports. Wells Fargo & Company‘s price target would suggest a potential upside of 52.04% from the company’s current price.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.